Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ascrinvacumab by Kintor Pharmaceutical for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval
Ascrinvacumab is under clinical development by Kintor Pharmaceutical and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC). According to...
Pruxelutamide by Kintor Pharmaceutical for Hormone-Sensitive Prostate Cancer: Likelihood of Approval
Pruxelutamide is under clinical development by Kintor Pharmaceutical and currently in Phase II for Hormone-Sensitive Prostate Cancer. According to GlobalData,...
Ascrinvacumab by Kintor Pharmaceutical for Liver Cancer: Likelihood of Approval
Ascrinvacumab is under clinical development by Kintor Pharmaceutical and currently in Phase I for Liver Cancer. According to GlobalData, Phase...
Pruxelutamide by Kintor Pharmaceutical for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Pruxelutamide is under clinical development by Kintor Pharmaceutical and currently in Phase III for Coronavirus Disease 2019 (COVID-19). According to...